These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 35978514)

  • 21. Microglial roles in Alzheimer's disease: An agent-based model to elucidate microglial spatiotemporal response to beta-amyloid.
    Weathered C; Bardehle S; Yoon C; Kumar N; Leyns CEG; Kennedy ME; Bloomingdale P; Pienaar E
    CPT Pharmacometrics Syst Pharmacol; 2024 Mar; 13(3):449-463. PubMed ID: 38078626
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of innate immune responses and neuroinflammation in amyloid accumulation and progression of Alzheimer's disease.
    Webers A; Heneka MT; Gleeson PA
    Immunol Cell Biol; 2020 Jan; 98(1):28-41. PubMed ID: 31654430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microglia in Alzheimer's Disease: A Favorable Cellular Target to Ameliorate Alzheimer's Pathogenesis.
    Sumsuzzman DM; Uddin MS; Kabir MT; Hasana S; Perveen A; Alanazi IS; Albadrani GM; Abdel-Daim MM; Ashraf GM
    Mediators Inflamm; 2022; 2022():6052932. PubMed ID: 35693110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activated human microglia stimulate neuroblastoma cells to upregulate production of beta amyloid protein and tau: implications for Alzheimer's disease pathogenesis.
    Lee M; McGeer E; McGeer PL
    Neurobiol Aging; 2015 Jan; 36(1):42-52. PubMed ID: 25169677
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dihydromyricetin inhibits microglial activation and neuroinflammation by suppressing NLRP3 inflammasome activation in APP/PS1 transgenic mice.
    Feng J; Wang JX; Du YH; Liu Y; Zhang W; Chen JF; Liu YJ; Zheng M; Wang KJ; He GQ
    CNS Neurosci Ther; 2018 Dec; 24(12):1207-1218. PubMed ID: 29869390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting Microglia in Alzheimer's Disease: From Molecular Mechanisms to Potential Therapeutic Targets for Small Molecules.
    Althafar ZM
    Molecules; 2022 Jun; 27(13):. PubMed ID: 35807370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How brain 'cleaners' fail: Mechanisms and therapeutic value of microglial phagocytosis in Alzheimer's disease.
    Ni J; Xie Z; Quan Z; Meng J; Qing H
    Glia; 2024 Feb; 72(2):227-244. PubMed ID: 37650384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microglial amyloid beta clearance is driven by PIEZO1 channels.
    Jäntti H; Sitnikova V; Ishchenko Y; Shakirzyanova A; Giudice L; Ugidos IF; Gómez-Budia M; Korvenlaita N; Ohtonen S; Belaya I; Fazaludeen F; Mikhailov N; Gotkiewicz M; Ketola K; Lehtonen Š; Koistinaho J; Kanninen KM; Hernández D; Pébay A; Giugno R; Korhonen P; Giniatullin R; Malm T
    J Neuroinflammation; 2022 Jun; 19(1):147. PubMed ID: 35706029
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deglycosylated anti-amyloid beta antibodies reduce microglial phagocytosis and cytokine production while retaining the capacity to induce amyloid beta sequestration.
    Takata K; Hirata-Fukae C; Becker AG; Chishiro S; Gray AJ; Nishitomi K; Franz AH; Sakaguchi G; Kato A; Mattson MP; Laferla FM; Aisen PS; Kitamura Y; Matsuoka Y
    Eur J Neurosci; 2007 Nov; 26(9):2458-68. PubMed ID: 17970733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CX3CL1 Pathway as a Molecular Target for Treatment Strategies in Alzheimer's Disease.
    Bivona G; Iemmolo M; Ghersi G
    Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175935
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease.
    Streit WJ; Braak H; Xue QS; Bechmann I
    Acta Neuropathol; 2009 Oct; 118(4):475-85. PubMed ID: 19513731
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microglia in Alzheimer's Disease: An Unprecedented Opportunity as Prospective Drug Target.
    Kulkarni B; Cruz-Martins N; Kumar D
    Mol Neurobiol; 2022 May; 59(5):2678-2693. PubMed ID: 35149973
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bone-Marrow-Derived Microglia-Like Cells Ameliorate Brain Amyloid Pathology and Cognitive Impairment in a Mouse Model of Alzheimer's Disease.
    Kawanishi S; Takata K; Itezono S; Nagayama H; Konoya S; Chisaki Y; Toda Y; Nakata S; Yano Y; Kitamura Y; Ashihara E
    J Alzheimers Dis; 2018; 64(2):563-585. PubMed ID: 29914020
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metformin attenuates plaque-associated tau pathology and reduces amyloid-β burden in APP/PS1 mice.
    Chen Y; Zhao S; Fan Z; Li Z; Zhu Y; Shen T; Li K; Yan Y; Tian J; Liu Z; Zhang B
    Alzheimers Res Ther; 2021 Feb; 13(1):40. PubMed ID: 33563332
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytokine-producing microglia have an altered beta-amyloid load in aged APP/PS1 Tg mice.
    Babcock AA; Ilkjær L; Clausen BH; Villadsen B; Dissing-Olesen L; Bendixen AT; Lyck L; Lambertsen KL; Finsen B
    Brain Behav Immun; 2015 Aug; 48():86-101. PubMed ID: 25774009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alpha7 nicotinic acetylcholine receptor-specific agonist DMXBA (GTS-21) attenuates Aβ accumulation through suppression of neuronal γ-secretase activity and promotion of microglial amyloid-β phagocytosis and ameliorates cognitive impairment in a mouse model of Alzheimer's disease.
    Takata K; Amamiya T; Mizoguchi H; Kawanishi S; Kuroda E; Kitamura R; Ito A; Saito Y; Tawa M; Nagasawa T; Okamoto H; Sugino Y; Takegami S; Kitade T; Toda Y; Kem WR; Kitamura Y; Shimohama S; Ashihara E
    Neurobiol Aging; 2018 Feb; 62():197-209. PubMed ID: 29175709
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nogo receptor impairs the clearance of fibril amyloid-β by microglia and accelerates Alzheimer's-like disease progression.
    Wang J; Qin X; Sun H; He M; Lv Q; Gao C; He X; Liao H
    Aging Cell; 2021 Dec; 20(12):e13515. PubMed ID: 34821024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microglial autophagy is impaired by prolonged exposure to β-amyloid peptides: evidence from experimental models and Alzheimer's disease patients.
    Pomilio C; Gorojod RM; Riudavets M; Vinuesa A; Presa J; Gregosa A; Bentivegna M; Alaimo A; Alcon SP; Sevlever G; Kotler ML; Beauquis J; Saravia F
    Geroscience; 2020 Apr; 42(2):613-632. PubMed ID: 31975051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroimmune Dysfunction in Alzheimer's Disease and Other Forms of Dementia.
    Yamane T; Yoshioka T; Shimo Y
    Chem Pharm Bull (Tokyo); 2024; 72(7):618-629. PubMed ID: 38945938
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TLR4 Cross-Talk With NLRP3 Inflammasome and Complement Signaling Pathways in Alzheimer's Disease.
    Yang J; Wise L; Fukuchi KI
    Front Immunol; 2020; 11():724. PubMed ID: 32391019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.